Related Experiment Video
Updated: Sep 16, 2025

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
DNA2 protein destruction dictates DNA hyperexcision, cGAS-STING activation, and innate immune response in
Rui Sun1,2,3, Peng Jiang1, Zhijun Wang4
1Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Abstract:
CDK12 primarily functions as a transcription regulatory cyclin-dependent kinase (CDK) that controls mRNA elongation, splicing, and polyadenylation. The CDK12 gene is implicated in human cancers since it is frequently mutated and/or deleted in prostate and ovarian cancer but paradoxically amplified in breast cancer. Here, we demonstrate that CDK12 promotes serine-933 phosphorylation of DNA2, a nuclease/helicase critical for replication fork stress regulation, and the phosphorylation subsequently facilitates DNA2 polyubiquitination and degradation mediated by the APC/CCDC20 E3 ubiquitin ligase. CDK12 inactivation induces but amplification suppresses genome-wide expression of interferon response and antigen processing and presentation machinery genes in ovarian and breast cancer cells, respectively. Besides causing aberrant DNA2 stabilization, replication stress, genomic instability, and cytosolic double-stranded DNA (dsDNA) accumulation, CDK12 loss also triggers cGAS-STING activation and innate immune response, which can be reversed by forced expression of replication protein A (RPA) subunits or DNA2 depletion. Our findings identify DNA2 as a phosphorylation substrate of CDK12, connecting CDK12 to cell cycle regulation. These data also reveal DNA2 protein destruction as a critical mechanism that dictates genomic instability, cGAS-STING signaling activation, and innate immune response in CDK12-deregulated cancers.
Insights
CDK12 regulates DNA2 stability, impacting cancer cell genome integrity and immune response. Its inactivation triggers DNA damage and innate immunity, while amplification suppresses it, highlighting CDK12
Area of Science:
- Molecular Biology
- Cancer Biology
- Immunology
Background:
- CDK12 is a transcription regulatory kinase implicated in various cancers.
- CDK12 mutations/deletions are found in prostate and ovarian cancers, while amplification occurs in breast cancer.
Purpose of the Study:
- To investigate the role of CDK12 in DNA2 regulation and its downstream effects on cancer cells.
- To elucidate the connection between CDK12, DNA2 stability, and the innate immune response.
Main Methods:
- Investigated CDK12's effect on DNA2 phosphorylation and ubiquitination.
- Analyzed gene expression changes in response to CDK12 inactivation or amplification.
- Assessed replication stress, genomic instability, and cGAS-STING pathway activation.
Main Results:
- CDK12 phosphorylates DNA2 at serine-933, promoting its degradation via APC/CCDC20.
- CDK12 inactivation leads to DNA2 stabilization, replication stress, genomic instability, and cGAS-STING activation.
- CDK12 amplification suppresses interferon response genes.
Conclusions:
- DNA2 is a novel phosphorylation substrate of CDK12, linking CDK12 to cell cycle regulation.
- CDK12-mediated DNA2 destruction is critical for preventing genomic instability and cGAS-STING signaling in cancer.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Negative Regulator Molecules

